An Analysis of the Vitamin D Ingredients Market by Vitamin D2 and Vitamin D3 Ingredients 2023 to 2033

<p>The rising cases of vitamin D deficiency and health issues related to it and increasing health awareness among consumers have helped the global <strong>vitamin D ingredients market </strong>to have a strong and steady growth. Currently, the global vitamin D ingredients market is valued at US$ 1,560 million and is expected to register a CAGR of 5.9% allowing it to reach a great market value of US$ 2,780.3 million.</p><table><tbody><tr><th scope='row'>Attributes</th><td>Details</td></tr><tr><th scope='row'>Vitamin D Ingredients Market Size (2023)</th><td>US$ 1,560 million</td></tr><tr><th scope='row'>Anticipated Vitamin D Ingredients Market Size (2033)</th><td>US$ 2,780.3 million</td></tr><tr><th scope='row'>Vitamin D Ingredients Market Expected CAGR (2023 to 2033)</th><td>5.9%</td></tr></tbody></table><p>Scope of the Report</p><table><tbody><tr><th scope='row'>Attributes</th><td>Details</td></tr><tr><th scope='row'>Market Size Value in 2023</th><td>US$ 1560 million</td></tr><tr><th scope='row'>Market Forecast Value in 2033</th><td>US$ 2780.3 million</td></tr><tr><th scope='row'>Global Growth Rate</th><td>5.9% CAGR</td></tr><tr><th scope='row'>Forecast Period</th><td>2023 to 2033</td></tr><tr><th scope='row'>Historical Data Available for</th><td>2018 to 2022</td></tr><tr><th scope='row'>Market Analysis</th><td>MT for Volume and US$ million for Value</td></tr><tr><th scope='row'>Key Regions Covered</th><td><ul><li>North America</li><li>Latin America</li><li>Western Europe</li><li>Eastern Europe</li><li>South Asia &amp; Pacific</li><li>East Asia</li><li>Middle East &amp; Africa</li></ul></td></tr><tr><th scope='row'>Key Countries Covered</th><td><ul><li>United States</li><li>Canada</li><li>Brazil</li><li>Mexico</li><li>Germany</li><li>United Kingdom</li><li>France</li><li>Spain</li><li>Italy</li><li>Russia</li><li>Poland</li><li>Czech</li><li>Republic</li><li>Romania</li><li>China</li><li>Japan</li><li>South Korea</li><li>India</li><li>Bangladesh</li><li>Australia</li><li>New Zealand</li><li>GCC countries</li><li>South Africa</li><li>Israel</li></ul></td></tr><tr><th scope='row'>Kay Segments Covered</th><td><ul><li>Product Type</li><li>Source</li><li>Application</li><li>Region</li></ul></td></tr><tr><th scope='row'>Key Companies Profiles</th><td><ul><li>Koninkljike DSM N.V</li><li>Zhejiang Xinhecheng Co Ltd</li><li>BASF Se</li><li>Fermenta Biotech Ltd</li><li>PHW Group</li><li>Synthesia</li><li>Bio-Tech Pharmacal</li><li>McKinley Resources Inc</li><li>Taizhou Hisound Pharmaceutical Co Ltd</li><li>Stabicoat Vitamins</li></ul></td></tr><tr><th scope='row'>Customization &amp; Pricing</th><td>Available Upon Request</td></tr></tbody></table>

<p>维他命D缺乏症案例的上升及其相关健康问题，以及消费者健康意识的不断提高，共同推动了全球维他命D原料市场的强劲且持续增长。目前，全球维他命D原料市场的价值已达15.6亿美元，预计将以5.9%的复合年增长率（CAGR）增长，届时市场规模将达到278.03亿美元。</p><table><tbody><tr><th scope='row'>属性</th><td>详细信息</td></tr><tr><th scope='row'>2023年维他命D原料市场规模</th><td>15.6亿美元</td></tr><tr><th scope='row'>预计2033年维他命D原料市场规模</th><td>278.03亿美元</td></tr><tr><th scope='row'>预计2023年至2033年维他命D原料市场复合年增长率</th><td>5.9%</td></tr></tbody></table><p>报告范围</p><table><tbody><tr><th scope='row'>属性</th><td>详细信息</td></tr><tr><th scope='row'>2023年市场规模价值</th><td>15.6亿美元</td></tr><tr><th scope='row'>2033年市场预测价值</th><td>278.03亿美元</td></tr><tr><th scope='row'>全球增长率</th><td>5.9% CAGR</td></tr><tr><th scope='row'>预测期</th><td>2023年至2033年</td></tr><tr><th scope='row'>可提供历史数据的时间段</th><td>2018年至2022年</td></tr><tr><th scope='row'>市场分析</th><td>以体积计的MT和以百万美元计的价值</td></tr><tr><th scope='row'>涵盖的关键地区</th><td><ul><li>北美</li><li>拉丁美洲</li><li>西欧</li><li>东欧</li><li>南亚及太平洋地区</li><li>东亚</li><li>中东及非洲</li></ul></td></tr><tr><th scope='row'>涵盖的关键国家</th><td><ul><li>美国</li><li>加拿大</li><li>巴西</li><li>墨西哥</li><li>德国</li><li>英国</li><li>法国</li><li>西班牙</li><li>意大利</li><li>俄罗斯</li><li>波兰</li><li>捷克共和国</li><li>罗马尼亚</li><li>中国</li><li>日本</li><li>韩国</li><li>印度</li><li>孟加拉国</li><li>澳大利亚</li><li>新西兰</li><li>GCC国家</li><li>南非</li><li>以色列</li></ul></td></tr><tr><th scope='row'>涵盖的关键细分市场</th><td><ul><li>产品类型</li><li>来源</li><li>应用</li><li>地区</li></ul></td></tr><tr><th scope='row'>关键公司概览</th><td><ul><li>Koninkljike DSM N.V</li><li>浙江新和成股份有限公司</li><li>BASF SE</li><li>Fermenta Biotech Ltd</li><li>PHW集团</li><li>Synthesia</li><li>生物制药公司</li><li>麦金利资源公司</li><li>台州汇音制药有限公司</li><li>Stabicoat维他命</li></ul></td></tr><tr><th scope='row'>定制及定价</th><td>根据要求提供</td></tr></tbody></table>